Evidence map›Paper›PMID 30104567›Full record

ArticleNature communications2018

Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.

Xuemei Ji, Yohan Bossé, Maria Teresa Landi, Jiang Gui, Xiangjun Xiao, David Qian, Philippe Joubert, Maxime Lamontagne, Yafang Li, Ivan Gorlov and 114 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

124 authors.

Xuemei JiBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Yohan BosséDepartment of Molecular Medicine, Laval University, Québec, G1V 4G5, Canada.ORCID http://orcid.org/0000-0002-3067-3711
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Jiang GuiBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Xiangjun XiaoBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
David QianBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Philippe JoubertInstitut universitaire de cardiologie et de pneumologie de Québec, Québec, G1V 4G5, Canada.
Maxime LamontagneInstitut universitaire de cardiologie et de pneumologie de Québec, Québec, G1V 4G5, Canada.
Yafang LiBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Ivan GorlovBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Mariella de BiasiAnnenberg School of Communication, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Younghun HanBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Olga GorlovaBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, M5T 3L9, Canada.
Xifeng WuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA.ORCID http://orcid.org/0000-0001-5174-3769
James McKayInternational Agency for Research on Cancer, World Health Organization, Lyon, 69372 CEDEX 08, France.
Xuchen ZongLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, M5T 3L9, Canada.
Robert Carreras-TorresInternational Agency for Research on Cancer, World Health Organization, Lyon, 69372 CEDEX 08, France.
David C ChristianiDepartment of Environmental Health, Harvard School of Public Health, Boston, 02115, MA, USA.
Neil CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Mattias JohanssonInternational Agency for Research on Cancer, World Health Organization, Lyon, 69372 CEDEX 08, France.
Geoffrey LiuLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, M5T 3L9, Canada.
Stig E BojesenDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Herlev 2730, Denmark.ORCID http://orcid.org/0000-0002-4061-4133
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, 96813, HI, USA.
Demetrios AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Heike BickeböllerDepartment of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, 37073, Germany.
Melinda C AldrichDepartment of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, 37203, TN, USA.
William S BushDepartment of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, 37203, TN, USA.
Adonina TardonFaculty of Medicine, University of Oviedo, Oviedo, 33006, Spain.
Gad RennertClalit National Cancer Control Center, Carmel Medical Center, Haifa, 34361, Israel.ORCID http://orcid.org/0000-0002-8512-068X
Chu ChenPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, 98109, WA, USA.
M Dawn TeareSchool of Health and Related Research, University of Sheffield, Sheffield, S1 4DA, UK.
John K FieldRoy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3BX, UK.
Lambertus A KiemeneyRadboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, 6525 EZ, The Netherlands.
Philip LazarusDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, 99210-1495, WA, USA.
Aage HaugenNational Institute of Occupational Health, 0033, Gydas vei 8, 0033, Oslo, Norway.
Stephen LamBritish Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, V5Z1L3, Canada.
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, 33612, FL, USA.ORCID http://orcid.org/0000-0003-3241-3216
Angeline S AndrewDepartment of Epidemiology, Geisel School of Medicine, 1 Medical Center Drive, Hanover, 03755, NH, USA.
Hongbing ShenDepartment of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Nanjing, 211166, PR China.
Yun-Chul HongDepartment of Preventive Medicine, Seoul National University College of Medicine, 1 Gwanak-ro, Gwanak-gu, Seoul, 151 742, Republic of Korea.
Jian-Min YuanUniversity of Pittsburgh Cancer Institute, Pittsburgh, 15232, PA, USA.
Pier A BertazziDepartment of Preventive Medicine, IRCCS Foundation Ca'Granda Ospedale Maggiore Policlinico, Milan, 20133, Italy.ORCID http://orcid.org/0000-0003-3475-2449
Angela C PesatoriDepartment of Preventive Medicine, IRCCS Foundation Ca'Granda Ospedale Maggiore Policlinico, Milan, 20133, Italy.ORCID http://orcid.org/0000-0002-0261-3252
Yuanqing YeDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA.
Nancy DiaoDepartment of Environmental Health, Harvard School of Public Health, Boston, 02115, MA, USA.
Li SuDepartment of Environmental Health, Harvard School of Public Health, Boston, 02115, MA, USA.
Ruyang ZhangDepartment of Environmental Health, Harvard School of Public Health, Boston, 02115, MA, USA.
Yonathan BrhaneLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, M5T 3L9, Canada.
Natasha LeighlUniversity Health Network-The Princess Margaret Cancer Centre, 600 University Avenue, Toronto, M5G 2C4, Canada.
Jakob S JohansenDepartment of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, 2730, Denmark.
Anders MellemgaardDepartment of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, 2730, Denmark.
Walid SalibaClalit National Cancer Control Center, Carmel Medical Center, Haifa, 34361, Israel.
Christopher HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, 90033, CA, USA.
Lynne WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, 96813, HI, USA.
Ana Fernandez-SomoanoFaculty of Medicine, University of Oviedo, Oviedo, 33006, Spain.ORCID http://orcid.org/0000-0002-8135-9079
Guillermo Fernandez-TardonFaculty of Medicine, University of Oviedo, Oviedo, 33006, Spain.
Erik H F M van der HeijdenRadboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, 6525 EZ, The Netherlands.ORCID http://orcid.org/0000-0003-3596-518X
Jin Hee KimDepartment of Integrative Bioscience & Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05029, Republic of Korea.ORCID http://orcid.org/0000-0003-1204-7079
Juncheng DaiDepartment of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Nanjing, 211166, PR China.
Zhibin HuDepartment of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Nanjing, 211166, PR China.
Michael P A DaviesRoy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3BX, UK.
Michael W MarcusRoy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3BX, UK.
Hans BrunnströmDepartment of Pathology, Lund University, Lund, 222 41, Sweden.
Jonas ManjerFaculty of Medicine, Lund University, Lund, 22100, Sweden.
Olle MelanderFaculty of Medicine, Lund University, Lund, 22100, Sweden.
David C MullerSchool of Public Health, St Mary's Campus, Imperial College London, London, W2 1PG, UK.ORCID http://orcid.org/0000-0002-2350-0417
Kim OvervadFaculty of Medicine, Lund University, Lund, 22100, Sweden.
Antonia TrichopoulouHellenic Health Foundation, Athens, GR-115 27, Greece.
Rosario TuminoCancer Registry and Histopathology Department, "Civic-M.P. Arezzo" Hospital, ASP, Ragusa, 97100, Italy.
Jennifer DohertyDepartment of Epidemiology, Geisel School of Medicine, 1 Medical Center Drive, Hanover, 03755, NH, USA.
Gary E GoodmanFred Hutchinson Cancer Research Center, Seattle, 98109-1024, WA, USA.
Angela CoxDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2RX, UK.ORCID http://orcid.org/0000-0002-5138-1099
Fiona TaylorDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2RX, UK.
Penella WollDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2RX, UK.
Irene BrüskeResearch Unit of Molecular Epidemiology, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, D-85764, Germany.
Judith ManzResearch Unit of Molecular Epidemiology, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, D-85764, Germany.
Thomas MuleyThoraxklinik at University Hospital Heidelberg, Heidelberg, 69126, Germany.
Angela RischCancer Cluster Salzburg, University of Salzburg, Salzburg, 5020, Austria.ORCID http://orcid.org/0000-0002-8026-5505
Albert RosenbergerDepartment of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, 37073, Germany.
Kjell GrankvistDepartment of Medical Biosciences, Umeå University, Umeå, 901 85, Sweden.ORCID http://orcid.org/0000-0003-4289-2097
Mikael JohanssonDepartment of Radiation Sciences, Umeå University, Umeå, 901 85, Sweden.
Frances ShepherdPrincess Margaret Cancer Centre, Toronto, M5G2M9, Canada.
Ming-Sound TsaoPrincess Margaret Cancer Centre, Toronto, M5G2M9, Canada.
Susanne M ArnoldMarkey Cancer Center, University of Kentucky, First Floor, 800 Rose Street, Lexington, 40508, KY, USA.ORCID http://orcid.org/0000-0001-6542-9551
Eric B HauraDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, 33612, KY, USA.
Ciprian BolcaInstitute of Pneumology "Marius Nasta", Bucharest, RO-050159, Romania.
Ivana Holcatova1st Faculty of Medicine, Charles University, Kateřinská 32, Prague, 121 08 Praha 2, Czech Republic.
Vladimir Janout1st Faculty of Medicine, Charles University, Kateřinská 32, Prague, 121 08 Praha 2, Czech Republic.
Milica KonticClinical Center of Serbia, Clinic for Pulmonology, School of Medicine, University of Belgrade, Belgrade, 11000, Serbia.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Institute-Oncology Center, Warsaw, 02-781, Poland.
Anush MukeriaDepartment of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, Moscow, 115478, Russian Federation.
Simona OgnjanovicInternational Organization for Cancer Prevention and Research, Belgrade, 11070, Serbia.
Tadeusz M OrlowskiDepartment of Surgery, National Tuberculosis and Lung Diseases Research Institute, Warsaw, PL-01-138, Poland.
Ghislaine SceloInternational Agency for Research on Cancer, World Health Organization, Lyon, 69372 CEDEX 08, France.
Beata SwiatkowskaDepartment of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, 91-348, Poland.
David ZaridzeDepartment of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, Moscow, 115478, Russian Federation.
Per BakkeDepartment of Clinical Science, University of Bergen, Bergen, 5021, Norway.
Vidar SkaugNational Institute of Occupational Health, 0033, Gydas vei 8, 0033, Oslo, Norway.
Shanbeh ZienolddinyNational Institute of Occupational Health, 0033, Gydas vei 8, 0033, Oslo, Norway.
Eric J DuellUnit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, 08908, Spain.
Lesley M ButlerUniversity of Pittsburgh Cancer Institute, Pittsburgh, 15232, PA, USA.
Woon-Puay KohDuke-NUS Medical School, Singapore, 119077, Singapore.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, 2200, China.
Richard HoulstonThe Institute of Cancer Research, London, SW7 3RP, England, UK.ORCID http://orcid.org/0000-0002-5268-0242
John McLaughlinPublic Health Ontario, Windsor, Ontario, N8W 5K5, Canada.
Victoria StevensAmerican Cancer Society, Inc., Atlanta, 30303, GA, USA.
David C NickleDepartment of Genetics and Pharmacogenomics, Merck Research Laboratories, Boston, 02115-5727, MA, USA.
Ma'en ObeidatCentre for Heart Lung Innovation, St Paul's Hospital, The University of British Columbia, Vancouver, V6Z 1Y6, BC, Canada.ORCID http://orcid.org/0000-0002-5443-2752
Wim TimensDepartment of Pathology and Medical Biology, GRIAC, University of Groningen, University Medical Center Groningen, Groningen, NL - 9713 GZ, The Netherlands.ORCID http://orcid.org/0000-0002-4146-6363
Bin ZhuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Lei SongDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
María Soler ArtigasGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.
Martin D TobinGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.ORCID http://orcid.org/0000-0002-3596-7874
Louise V WainGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.
Fangyi GuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Jinyoung ByunBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Ahsan KamalBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Dakai ZhuBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA.
Rachel F TyndaleDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, M5S 1A8, ON, Canada.
Wei-Qi WeiDepartment of Biomedical Informatics, School of Medicine, Vanderbilt University, Nashville, TN, 37235, USA.
Stephen ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Paul BrennanInternational Agency for Research on Cancer, World Health Organization, Lyon, 69372 CEDEX 08, France.ORCID http://orcid.org/0000-0002-0518-8714
Christopher I AmosBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, 03750, NH, USA. chrisa@bcm.edu.ORCID http://orcid.org/0000-0002-8540-7023

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V. · 1996 to 2024
$57.4M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Jennifer F Rogers · 2013 to 2026
$38.3M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos · 2017 to 2026
$23.7M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyZIACP010195 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$22.5M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2003 to 2011
$21.9M
VALIDATION OF A DIET HISTORY METHOD FOR EPIDEMIOLOGIC STUDIES OF CANCERP01CA033619 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1985 to 2010
$18.5M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Medical Research Council G0902313NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR000445NCI NIH HHS K07 CA172294NCI NIH HHS P01 CA033619NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA023108NCI NIH HHS P30 CA076292NCI NIH HHS P30 CA177558NCI NIH HHS P50 CA070907NCI NIH HHS P50 CA090578NCI NIH HHS P50 CA119997NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R01 CA144034NCI NIH HHS R01 CA151989NCI NIH HHS R01 CA176568NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA167462NCI NIH HHS U19 CA148127NCI NIH HHS U19 CA203654NCI NIH HHS UM1 CA164973NCI NIH HHS UM1 CA167462NCI NIH HHS UM1 CA182876NCRR NIH HHS P20 RR018787NCRR NIH HHS S10 RR025141NHGRI NIH HHS U01 HG004798NHLBI NIH HHS R01 HL133786NIGMS NIH HHS P20 GM103534NLM NIH HHS R01 LM012012Wellcome Trust 202849/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) identified the chromosome 15q25.1 locus as a leading susceptibility region for lung cancer. However, the pathogenic pathways, through which susceptibility SNPs within chromosome 15q25.1 affects lung cancer risk, have not been explored. We analyzed three cohorts with GWAS data consisting 42,901 individuals and lung expression quantitative trait loci (eQTL) data on 409 individuals to identify and validate the underlying pathways and to investigate the combined effect of genes from the identified susceptibility pathways. The KEGG neuroactive ligand receptor interaction pathway, two Reactome pathways, and 22 Gene Ontology terms were identified and replicated to be significantly associated with lung cancer risk, with P values less than 0.05 and FDR less than 0.1. Functional annotation of eQTL analysis results showed that the neuroactive ligand receptor interaction pathway and gated channel activity were involved in lung cancer risk. These pathways provide important insights for the etiology of lung cancer.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAgedChildChild, PreschoolChromosomes, Human, Pair 15Cohort StudiesFemaleGene OntologyGene Regulatory NetworksHumansInfantInfant, NewbornLung NeoplasmsMale

Identifiers

PMID30104567
PMCPMC6089967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.